<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mes</journal-id><journal-title-group><journal-title xml:lang="ru">Экстремальная биомедицина</journal-title><trans-title-group xml:lang="en"><trans-title>Extreme Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3033-8964</issn><issn pub-type="epub">3033-8972</issn><publisher><publisher-name>Centre for Strategic Planning of the Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47183/mes.2024.004</article-id><article-id custom-type="elpub" pub-id-type="custom">mes-121</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Взаимосвязь уровней гистамина, диаминоксидазы и субстанции P в сыворотке крови у пациентов с хронической крапивницей</article-title><trans-title-group xml:lang="en"><trans-title>Correlations between serum levels of histamine, diamine oxidase, substance P in patients with chronic urticaria</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Микрюкова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikryukova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Васильевна Микрюкова</p><p>ул. Оптиков, д. 54, г. Санкт-Петербург, 197345</p></bio><bio xml:lang="en"><p>Natalya V. Mikryukova</p><p>Optikov, 54, Saint Petersburg, 197345</p></bio><email xlink:type="simple">natalya@mikryukov.info</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калинина</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalinina</surname><given-names>N. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Всероссийский центр экстренной и радиационной медицины имени А. М. Никифорова МЧС России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Всероссийский центр экстренной и радиационной медицины имени А. М. Никифорова МЧС России; Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia; Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2024</year></pub-date><volume>26</volume><issue>1</issue><fpage>81</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Микрюкова Н.В., Калинина Н.М., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Микрюкова Н.В., Калинина Н.М.</copyright-holder><copyright-holder xml:lang="en">Mikryukova N.V., Kalinina N.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.extrememedicine.ru/jour/article/view/121">https://www.extrememedicine.ru/jour/article/view/121</self-uri><abstract><p>Возникновение и прогрессирование различных заболеваний, в том числе хронической крапивницы, связаны со стрессом. Ось кишечник-мозг-кожа используют для объяснения корреляций между состоянием нервной системы, желудочно-кишечного тракта, а также системным и местным воспалением в коже. В контексте оси кишечник-мозг-кожа мы обобщили воспалительные и иммунные механизмы хронической крапивницы и стресса. Целью нашего исследования было показать взаимосвязь между нейротрансмиттером субстанцией Р и диаминоксидазой, ферментом, разрушающим гистамин в кишечнике у пациентов, страдающих хронической крапивницей. В исследование было включено 165 взрослых людей от 18 до 68 лет, 97 пациентов страдали хронической крапивницей, группу сравнения составили 68 условно здоровых лиц. Методом ИФА (Cloud-Clone Corp; Китай) одновременно оценивали уровни субстанции Р, диаминоксидазы и гистамина в сыворотке крови. Была выявлена прямая заметная корреляционная связь (ρ = 0,5; p &lt; 0,05) между субстанцией Р и диаминоксидазой у пациентов, страдающих хронической крапивницей, и в группе сравнения, что подтвердило наличие оси кишечник-мозг-кожа. В статье представлены теоретическая основа и новые цели для лечения хронической крапивницы. Обсуждена возможность предотвратить и лечить эти патологические состояния путем модуляции микробиоты кишечника, определены место диеты и изменения образа жизни, способствующие улучшению состояния здоровья в целом.</p></abstract><trans-abstract xml:lang="en"><p>The onset and progression of various disorders, including chronic urticaria, are associated with stress. The gut-brain-skin axis is used to describe correlations among the nervous system, gastrointestinal tract states and systemic and skin inflammation. We have summarized inflammatory and immune mechanisms underlying chronic urticaria and stress in the context of the gut-brain-skin axis. The study was aimed to show the relationships between substance P, the neurotransmitter, and diamine oxidase, the enzyme disrupting histamine in the gut of patients suffering from chronic urticaria. A total of 165 adults aged 18–68 were enrolled; 97 patients had chronic urticaria, the comparison group was formed of 68 nominally healthy individuals. ELISA (Cloud-Clone Corp; China) was used to simultaneously estimate serum levels of substance P, diamine oxidase, and histamine. We revealed a significant positive correlation (ρ = 0.5; p &lt; 0.05) between substance P and diamine oxidase in patients with chronic urticaria and in the comparison group, which confirmed the existence of the gut-brain-skin axis. The paper provides theoretical background and new targets for treatment of chronic urticaria. The possibility of prevention and treatment of these disorders by modulation of gut microbiota is discussed, the place of diet and the lifestyle modification contributing to improvement of general health are determined.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>субстанция P</kwd><kwd>диаминоксидаза</kwd><kwd>гистамин</kwd><kwd>хроническая крапивница</kwd><kwd>стресс</kwd><kwd>ось кишечник-мозг-кожа</kwd></kwd-group><kwd-group xml:lang="en"><kwd>substance P</kwd><kwd>diamine oxidase</kwd><kwd>histamine</kwd><kwd>chronic urticaria</kwd><kwd>stress</kwd><kwd>gut-brain-skin axis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">исследование выполнено при финансовой поддержке «ВЦЭРМ им. А. М. Никифорова» МЧС России в рамках НИР «Клинико- лабораторная диагностика хронической крапивницы у взрослых».</funding-statement><funding-statement xml:lang="en">the study was supported by the Nikiforov's All-Russian Center for Emergency and Radiation Medicine, EMERCOM of Russia, within the framework  of the research project “Clinical and laboratory diagnosis of chronic urticaria in adults”</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology. 2000; 22 (2): 108–24.</mixed-citation><mixed-citation xml:lang="en">McEwen BS. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology. 2000; 22 (2): 108–24.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Musazzi L, Tornese P, Sala N, Popoli M. What acute stress protocols can tell us about PTSD and stress-related neuropsychiatric disorders. Front Pharmacol. 2018; 12 (9): 758. DOI: 10.3389/fphar.2018.00758. PMID: 30050444.</mixed-citation><mixed-citation xml:lang="en">Musazzi L, Tornese P, Sala N, Popoli M. What acute stress protocols can tell us about PTSD and stress-related neuropsychiatric disorders. Front Pharmacol. 2018; 12 (9): 758. DOI: 10.3389/fphar.2018.00758. PMID: 30050444.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Malagelada JR. The brain-gut team. Dig Dis. 2020; 38 (4): 293–8. DOI: 10.1159/000505810. PMID: 32114574.</mixed-citation><mixed-citation xml:lang="en">Malagelada JR. The brain-gut team. Dig Dis. 2020; 38 (4): 293–8. DOI: 10.1159/000505810. PMID: 32114574.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen P, Zhang L, Feng Y, Liu YF, Si TL, Su Z, et al. Brain-gut axis and psychiatric disorders: A perspective from bibliometric and visual analysis. Front Immunol. 2022; 16 (13): 1047007. DOI: 10.3389/fimmu.2022.1047007. PMID: 36466907.</mixed-citation><mixed-citation xml:lang="en">Chen P, Zhang L, Feng Y, Liu YF, Si TL, Su Z, et al. Brain-gut axis and psychiatric disorders: A perspective from bibliometric and visual analysis. Front Immunol. 2022; 16 (13): 1047007. DOI: 10.3389/fimmu.2022.1047007. PMID: 36466907.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Шаповалова Н. С. Ось кишечник-мозг и ее роль в развитии функциональных гастроинтестинальных расстройств. Children's Medicine of the North-West. 2021; 9 (4): 33–50.</mixed-citation><mixed-citation xml:lang="en">Shapovalova NS. The role of the gut-brain axis in functional gastrointestinal disorders. Children's Medicine of the North-West. 2021; 9 (4): 33–50. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Lyga J. Brain-skin connection: stress, inflammation and skin aging. Inflamm Allergy Drug Targets. 2014; 13 (3): 177–90. DOI: 10.2174/1871528113666140522104422. PMID: 24853682.</mixed-citation><mixed-citation xml:lang="en">Chen Y, Lyga J. Brain-skin connection: stress, inflammation and skin aging. Inflamm Allergy Drug Targets. 2014; 13 (3): 177–90. DOI: 10.2174/1871528113666140522104422. PMID: 24853682.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28: 203–9.</mixed-citation><mixed-citation xml:lang="en">Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28: 203–9.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 2016; 21 (6): 797–805.</mixed-citation><mixed-citation xml:lang="en">Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 2016; 21 (6): 797–805.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018; 359 (6375): 592–7.</mixed-citation><mixed-citation xml:lang="en">Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018; 359 (6375): 592–7.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Благонравова А. С., Галова Е. А., Широкова И. Ю., Галова Д. А. Ось «кишечник-мозг» — результаты клинического исследования. Экспериментальная и клиническая гастроэнтерология. 2023; 6: 5–13. DOI: 10.31146/1682-8658-ecg-214-6-5-13.</mixed-citation><mixed-citation xml:lang="en">Blagonravova AS, Galova EA, Shirokova IYu, Galova DA. The gut-brain axis — clinical study results. Experimental and Clinical Gastroenterology. 2023; 6: 5–13. DOI: 10.31146/1682-8658-ecg-214-6-5-13. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Брсикян Л. А., Полуэктова Е. А., Полуэктов М. Г. Состояние микробиома кишечника как фактор развития болезни Паркинсона. Неврология, нейропсихиатрия, психосоматика. 2023; 15 (1): 90–6. DOI: 10.14412/2074-2711-2023-1-90-96.</mixed-citation><mixed-citation xml:lang="en">Brsikyan LA, Poluektova EA, Poluektov MG. The gut microbiome as a factor in the development of Parkinson's disease. Neurology, Neuropsychiatry, Psychosomatics. 2023; 15 (1): 90–6. DOI: 10.14412/2074-2711-2023-1-90-96. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuno K, Ueta H, Shu Z, Xue-Dong X, Sawanobori Y, Kitazawa Y, et al. The microstructure of secondary lymphoid organs that support immune cell trafficking. Arch Histol Cytol. 2010; 73: 1–21. DOI: 10.1679/aohc.73.1.</mixed-citation><mixed-citation xml:lang="en">Matsuno K, Ueta H, Shu Z, Xue-Dong X, Sawanobori Y, Kitazawa Y, et al. The microstructure of secondary lymphoid organs that support immune cell trafficking. Arch Histol Cytol. 2010; 73: 1–21. DOI: 10.1679/aohc.73.1.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Thye AY, Bah YR, Law JW, Tan LT, He YW, Wong SH, et al. Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. Biomedicines. 2022; 10 (5): 1037. DOI: 10.3390/biomedicines10051037. PMID: 35625774.</mixed-citation><mixed-citation xml:lang="en">Thye AY, Bah YR, Law JW, Tan LT, He YW, Wong SH, et al. Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. Biomedicines. 2022; 10 (5): 1037. DOI: 10.3390/biomedicines10051037. PMID: 35625774.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol. 2021; 39 (5): 829–39. DOI: 10.1016.</mixed-citation><mixed-citation xml:lang="en">Sinha S, Lin G, Ferenczi K. The skin microbiome and the gut-skin axis. Clin Dermatol. 2021; 39 (5): 829–39. DOI: 10.1016.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X, Li Y, Wu L, Xiao S, Ji Y, Tan Y, et al. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomed Pharmacother. 2021; 137: 111065. DOI: 10.1016/j.biopha.2020.111065.</mixed-citation><mixed-citation xml:lang="en">Wang X, Li Y, Wu L, Xiao S, Ji Y, Tan Y, et al. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomed Pharmacother. 2021; 137: 111065. DOI: 10.1016/j.biopha.2020.111065.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ferraretto A, Donetti E, García-Mena J, Pacheco-López G. Editorial: The gut-skin-brain axis in human health and disease. Front Nutr. 2023; 16 (10): 1155614. DOI: 10.3389/fnut.2023.1155614. PMID: 36875850.</mixed-citation><mixed-citation xml:lang="en">Ferraretto A, Donetti E, García-Mena J, Pacheco-López G. Editorial: The gut-skin-brain axis in human health and disease. Front Nutr. 2023; 16 (10): 1155614. DOI: 10.3389/fnut.2023.1155614. PMID: 36875850.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrine reviews. 2000; 21 (5): 457–87.</mixed-citation><mixed-citation xml:lang="en">Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrine reviews. 2000; 21 (5): 457–87.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Marek-Jozefowicz L, Czajkowski R, Borkowska A, Nedoszytko B, Żmijewski MA, Cubała WJ, et al. Axis in psoriasis-psychological, psychiatric, hormonal, and dermatological aspects. Int J Mol Sci. 2022; 23 (2): 669. DOI: 10.3390/ijms23020669. PMID: 35054853.</mixed-citation><mixed-citation xml:lang="en">Marek-Jozefowicz L, Czajkowski R, Borkowska A, Nedoszytko B, Żmijewski MA, Cubała WJ, et al. Axis in psoriasis-psychological, psychiatric, hormonal, and dermatological aspects. Int J Mol Sci. 2022; 23 (2): 669. DOI: 10.3390/ijms23020669. PMID: 35054853.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Andrzej TS, Michal AZ, Przemyslaw MP, Jerzy PS, Ralf P, How UV. Light touches the brain and endocrine system through skin, and why, endocrinology. 2018; 159 (5): 1992–2007. DOI: 10.1210/en.2017-03230.</mixed-citation><mixed-citation xml:lang="en">Andrzej TS, Michal AZ, Przemyslaw MP, Jerzy PS, Ralf P, How UV. Light touches the brain and endocrine system through skin, and why, endocrinology. 2018; 159 (5): 1992–2007. DOI: 10.1210/en.2017-03230.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Remröd C, Lonne-Rahm S, Nordlind K. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res. 2007; 299 (2): 85–91. DOI: 10.1007/s00403-007-0745-x.</mixed-citation><mixed-citation xml:lang="en">Remröd C, Lonne-Rahm S, Nordlind K. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res. 2007; 299 (2): 85–91. DOI: 10.1007/s00403-007-0745-x.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Asadi S, Alysandratos KD, Angelidou A, Miniati A, Sismanopoulos N, Vasiadi M, et al. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol. 2012; 132 (2): 324–9. DOI: 10.1038/jid.2011.334.</mixed-citation><mixed-citation xml:lang="en">Asadi S, Alysandratos KD, Angelidou A, Miniati A, Sismanopoulos N, Vasiadi M, et al. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol. 2012; 132 (2): 324–9. DOI: 10.1038/jid.2011.334.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mijouin L, Hillion M, Ramdani Y, Jaouen T, Duclairoir-Poc C, Follet-Gueye ML, et al. Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One. 2013; 8 (11): 78773.</mixed-citation><mixed-citation xml:lang="en">Mijouin L, Hillion M, Ramdani Y, Jaouen T, Duclairoir-Poc C, Follet-Gueye ML, et al. Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One. 2013; 8 (11): 78773.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Данилычева И. В., Ильина Н. И., Лусс Л. В. и др. Федеральные клинические рекомендации. Крапивница. Российский аллергологический журнал. 2018; 15 (5): 47–62.</mixed-citation><mixed-citation xml:lang="en">Danilicheva IV, Ilina NI, Luss LV, et al. Federal Clinical Recommendations. Urticaria. Russian Journal of Allergy. 2018; 15 (5): 47–62. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Smolinska S, Jutel M, Crameri R, O’Mahony L. Histamine and gut mucosal immune regulation. Allergy. 2013; 69 (3): 273–81. DOI: 10.1111/all.12330.</mixed-citation><mixed-citation xml:lang="en">Smolinska S, Jutel M, Crameri R, O’Mahony L. Histamine and gut mucosal immune regulation. Allergy. 2013; 69 (3): 273–81. DOI: 10.1111/all.12330.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Yusuke H, Hiroshi N, Minoru M, Tsutomu C. Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability. Inflammatory Bowel Diseases. 2011; 17 (2): 23–5. DOI: 10.1002/ibd.21588.</mixed-citation><mixed-citation xml:lang="en">Yusuke H, Hiroshi N, Minoru M, Tsutomu C. Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability. Inflammatory Bowel Diseases. 2011; 17 (2): 23–5. DOI: 10.1002/ibd.21588.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y, Yao R, Zhao W, et al. Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome. Heliyon. 2023; 9 (6): 16544. DOI: 10.1016/j.heliyon.2023.e16544.</mixed-citation><mixed-citation xml:lang="en">Xu Y, Yao R, Zhao W, et al. Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome. Heliyon. 2023; 9 (6): 16544. DOI: 10.1016/j.heliyon.2023.e16544.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Raskov H, Burcharth J, Pommergaard HC, Rosenberg J. Irritable bowel syndrome, the microbiota and the gutbrain axis. Gut Microbes. 2016; 7 (5): 365–83. DOI: 10.1080/19490976.2016.1218585.</mixed-citation><mixed-citation xml:lang="en">Raskov H, Burcharth J, Pommergaard HC, Rosenberg J. Irritable bowel syndrome, the microbiota and the gutbrain axis. Gut Microbes. 2016; 7 (5): 365–83. DOI: 10.1080/19490976.2016.1218585.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">McEwen BS. The untapped power of allostasis promoted by healthy lifestyles. World Psychiatry. 2020; 19 (1): 57–8. DOI: 10.1002/wps.20720. PMID: 31922670.</mixed-citation><mixed-citation xml:lang="en">McEwen BS. The untapped power of allostasis promoted by healthy lifestyles. World Psychiatry. 2020; 19 (1): 57–8. DOI: 10.1002/wps.20720. PMID: 31922670.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
